Editorial for “Association of Pathological Features and Multiparametric MRI‐Based Radiomics with TP53‐Mutated Prostate Cancer”

Journal of Magnetic Resonance ImagingEarly View Editorial Editorial for “Association of Pathological Features and Multiparametric MRI-Based Radiomics with TP53-Mutated Prostate Cancer” Satoru Takahashi MD, PhD, FJCR, Corresponding Author Satoru Takahashi MD, PhD, FJCR [email protected] orcid.org/0000-0001-6621-9206 Imaging Research Center, Takatsuki General Hospital, Takatsuki, Osaka, Japan Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan Address reprint requests to: S.T., Imaging Research Center, Takatsuki General Hospital, 1-3-13, Kosobe-cho, Takatsuki, Osaka, 569-1192, Japan. E-mail: [email protected]Search for more papers by this author Satoru Takahashi MD, PhD, FJCR, Corresponding Author Satoru Takahashi MD, PhD, FJCR [email protected] orcid.org/0000-0001-6621-9206 Imaging Research Center, Takatsuki General Hospital, Takatsuki, Osaka, Japan Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan Address reprint requests to: S.T., Imaging Research Center, Takatsuki General Hospital, 1-3-13, Kosobe-cho, Takatsuki, Osaka, 569-1192, Japan. E-mail: [email protected]Search for more papers by this author First published: 08 January 2024 https://doi.org/10.1002/jmri.29224 Level of Evidence: 5 Technical Efficacy: Stage 5 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Brady AP, Bello JA, Derchi LE, et al. Radiology in the era of value-based healthcare: A multi-society expert statement from the ACR, CAR, ESR, IS3R, RANZCR, and RSNA. Radiology 2021; 298(3): 486-491. 10.1148/radiol.2020209027 PubMedWeb of Science®Google Scholar 2Oerther B, Engel H, Bamberg F, Sigle A, Gratzke C, Benndorf M. Cancer detection rates of the PI-RADSv2.1 assessment categories: Systematic review and meta-analysis on lesion level and patient level. Prostate Cancer Prostatic Dis 2022; 25(2): 256-263. 10.1038/s41391-021-00417-1 CASPubMedWeb of Science®Google Scholar 3Eklund M, Jaderling F, Discacciati A, et al. MRI-targeted or standard biopsy in prostate cancer screening. N Engl J Med 2021; 385(10): 908-920. 10.1056/NEJMoa2100852 PubMedWeb of Science®Google Scholar 4Moch H, Amin MB, Berney DM, et al. The 2022 World Health Organization classification of Tumours of the urinary system and male genital organs-part a: Renal, penile, and testicular Tumours. Eur Urol 2022; 82(5): 458-468. 10.1016/j.eururo.2022.06.016 PubMedWeb of Science®Google Scholar 5Netto GJ, Amin MB, Berney DM, et al. The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-part B: Prostate and urinary tract tumors. Eur Urol 2022; 82(5): 469-482. 10.1016/j.eururo.2022.07.002 PubMedWeb of Science®Google Scholar 6Khan HM, Cheng HH. Germline genetics of prostate cancer. Prostate 2022; 82(1): S3-S12. 10.1002/pros.24340 CASPubMedGoogle Scholar 7Chen R, Zhou B, Liu W, Gan H, Liu X, Zhou L. Association of pathological features and multiparametric MRI-based radiomics with TP53-mutated prostate cancer. J Magn Reson Imaging 2023. https://doi.org/10.1002/jmri.29186. 10.1002/jmri.29186 Google Scholar 8Robinson D, Van Allen EM, Wu YM, et al. Integrative clinical genomics of advanced prostate cancer. Cell 2015; 161(5): 1215-1228. 10.1016/j.cell.2015.05.001 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation